股票行情快报：蓝帆医疗（002382）11月28日主力资金净买入71.14万元

Core Viewpoint - Bluefan Medical (002382) has shown a decline in stock price and financial performance, with significant net losses reported in recent quarters, indicating potential challenges in the medical device industry [1][3]. Financial Performance - As of November 28, 2025, Bluefan Medical's stock closed at 5.73 yuan, down 0.35%, with a trading volume of 76,600 hands and a transaction value of 43.58 million yuan [1]. - In the third quarter of 2025, the company reported a main revenue of 14.01 billion yuan, a year-on-year decrease of 15.02%, and a net profit attributable to shareholders of -1.51 billion yuan, a decline of 153.64% [3]. - For the first three quarters of 2025, the company's main revenue was 41.82 billion yuan, down 10.15%, with a net profit of -2.86 billion yuan, a decrease of 30.09% [3]. Market Position - Bluefan Medical's total market value is 5.771 billion yuan, significantly lower than the industry average of 11.144 billion yuan, ranking 62 out of 124 in the medical device sector [3]. - The company's net asset stands at 9.707 billion yuan, ranking 7 in the industry, while its net profit is the lowest in the sector at -2.86 billion yuan, ranking 124 [3]. - The company's price-to-earnings ratio is -15.14, and its price-to-book ratio is 0.75, indicating a low valuation compared to the industry average [3]. Capital Flow - On November 28, 2025, the net inflow of main funds was 711,400 yuan, accounting for 1.63% of the total transaction value, while retail investors saw a net outflow of 2.1339 million yuan, representing 4.9% of the total [1][2]. - Over the past five days, the stock has experienced fluctuating capital flows, with significant net outflows from retail investors on multiple days [2].